Androgen levels in adult females: changes with age, menopause, and oophorectomy.

By S. Davison, R. Bell, S. Donath, J. Montalto, Susan R. Davis, S. Davis. Journal of Clinical Endocrinology and Metabolism, 2005

961 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. (2004, background): “Retrospective data in women with polycystic ovaries suggest mortality occurs at a similar rate as in the general population and presumably at the same age (Dahlgren et al., 1992; Mulders et al., 2004; Davison et al., 2005; Alsamarai et al., 2009; Hudecova et al., 2009; Tehrani et al., 2010).”
Handbook of Clinical Sexuality for Mental Health Professionals (2004, background): “When a woman enters her 40s, she has approximately half the circulating testosterone level she once had.(8) There is no further significant decrease of testosterone after natural menopause as ovarian production of androgen precursors remains relatively continuous.”
Premature menopause or early menopause: long-term health consequences (2009, background): “Women undergoing bilateral oophorectomy continue to have lower levels of androgens than naturally menopausal women even beyond 65 years of age [48].”